Nanjing F&s Pharmatech

Manufacturer of APIs and pharmaceutical intermediates

placeNanjing, Jiangsu, China calendar_todayFounded 2015 language fshpharm.com

Innovation

74 patent families (10 granted) — focus: Chemistry & metallurgy, Physics & computing, Human necessities, Emerging technologies; filing pace accelerating. Cited 165 times.

YearFilings
20171
20181
201911
202116
20227
20234
202413
202521

Investor mix

4 investors on record; lead investors include Xiamen Financial Investment Group, Kaitai Capital Management.

Investor typeCountShare
Venture capital125%
Private equity125%
Other / undisclosed250%
Coming soon